Literature DB >> 7236329

Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis.

G Mintz, R D Enríquez, U Mercado, E J Robles, F J Jiménez, G Gutiérrez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236329     DOI: 10.1002/art.1780240521

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  11 in total

Review 1.  Spondylarthropathies: options for combination therapy.

Authors:  A M van Tubergen; R B Landewé; S van der Linden
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

Review 3.  Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Authors:  Nurullah Akkoc; Gercek Can; Salvatore D'Angelo; Angela Padula; Ignazio Olivieri
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

4.  Assessment and treatment of psoriatic spondylitis.

Authors:  Peter Nash
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

5.  The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.

Authors:  M B Richter; P Woo; G S Panayi; A Trull; A Unger; P Shepherd
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

Review 6.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

7.  Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy.

Authors:  G Nasswetter; D J Piñeiro; O M Garcia Morteo; J A Maldonado Cocco; J C Barreira; M Vazquez Blanco
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

8.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

9.  Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.

Authors:  J Kovarsky
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

Review 10.  Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Authors:  Juergen Braun; Joachim Sieper
Journal:  Arthritis Res       Date:  2002-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.